Literature DB >> 33768214

Possible Therapeutic Use of Natural Compounds Against COVID-19.

Nabab Khan1, Xuesong Chen1, Jonathan D Geiger1.   

Abstract

The outbreak of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has led to coronavirus disease-19 (COVID-19); a pandemic disease that has resulted in devastating social, economic, morbidity and mortality burdens. SARS-CoV-2 infects cells following receptor-mediated endocytosis and priming by cellular proteases. Following uptake, SARS-CoV-2 replicates in autophagosome-like structures in the cytosol following its escape from endolysosomes. Accordingly, the greater endolysosome pathway including autophagosomes and the mTOR sensor may be targets for therapeutic interventions against SARS-CoV-2 infection and COVID-19 pathogenesis. Naturally existing compounds (phytochemicals) through their actions on endolysosomes and mTOR signaling pathways might provide therapeutic relief against COVID-19. Here, we discuss evidence that some natural compounds through actions on the greater endolysosome system can inhibit SARS-CoV-2 infectivity and thereby might be repurposed for use against COVID-19.

Entities:  

Keywords:  Autophagy; COVID-19; Endolysosomes; Natural compounds; SARS-CoV-2

Year:  2021        PMID: 33768214      PMCID: PMC7990267     

Source DB:  PubMed          Journal:  J Cell Signal


  247 in total

1.  Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding.

Authors:  Bryan C Mounce; Teresa Cesaro; Lucia Carrau; Thomas Vallet; Marco Vignuzzi
Journal:  Antiviral Res       Date:  2017-03-24       Impact factor: 5.970

2.  mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport.

Authors:  Harry E Taylor; Nina Calantone; Drew Lichon; Hannah Hudson; Isabelle Clerc; Edward M Campbell; Richard T D'Aquila
Journal:  Cell Rep       Date:  2020-06-23       Impact factor: 9.423

3.  pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.

Authors:  Zhi-Yong Yang; Yue Huang; Lakshmanan Ganesh; Kwanyee Leung; Wing-Pui Kong; Owen Schwartz; Kanta Subbarao; Gary J Nabel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Mesenteric lymphatic absorption and the pharmacokinetics of naringin and naringenin in the rat.

Authors:  Yung-Jen Tsai; Tung-Hu Tsai
Journal:  J Agric Food Chem       Date:  2012-12-14       Impact factor: 5.279

Review 5.  Regulation of V-ATPase Assembly in Nutrient Sensing and Function of V-ATPases in Breast Cancer Metastasis.

Authors:  Michael P Collins; Michael Forgac
Journal:  Front Physiol       Date:  2018-07-13       Impact factor: 4.566

Review 6.  The Therapeutic Potential of Naringenin: A Review of Clinical Trials.

Authors:  Bahare Salehi; Patrick Valere Tsouh Fokou; Mehdi Sharifi-Rad; Paolo Zucca; Raffaele Pezzani; Natália Martins; Javad Sharifi-Rad
Journal:  Pharmaceuticals (Basel)       Date:  2019-01-10

7.  Polyamines: Potential anti-inflammatory agents and their possible mechanism of action.

Authors:  Chakradhar V Lagishetty; Suresh Ramnath Naik
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

Review 8.  Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71).

Authors:  Salima Lalani; Chit Laa Poh
Journal:  Viruses       Date:  2020-02-06       Impact factor: 5.048

9.  Spread of SARS-CoV-2 in the Icelandic Population.

Authors:  Daniel F Gudbjartsson; Agnar Helgason; Hakon Jonsson; Olafur T Magnusson; Pall Melsted; Gudmundur L Norddahl; Jona Saemundsdottir; Asgeir Sigurdsson; Patrick Sulem; Arna B Agustsdottir; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Gudmundur Georgsson; Olafia S Gretarsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Hilma Holm; Brynjar O Jensson; Aslaug Jonasdottir; Frosti Jonsson; Kamilla S Josefsdottir; Thordur Kristjansson; Droplaug N Magnusdottir; Louise le Roux; Gudrun Sigmundsdottir; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Arthur Löve; Gisli Masson; Ingileif Jonsdottir; Alma D Möller; Thorolfur Gudnason; Karl G Kristinsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  N Engl J Med       Date:  2020-04-14       Impact factor: 91.245

10.  Possible protective role of 17β-estradiol against COVID-19.

Authors:  Nabab Khan
Journal:  J Allergy Infect Dis       Date:  2020-08-19
View more
  7 in total

1.  Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression.

Authors:  Nabab Khan; Peter W Halcrow; Leo K Lakpa; Mohd Rehan; Xuesong Chen; Jonathan D Geiger
Journal:  J Neurovirol       Date:  2021-09-22       Impact factor: 2.643

2.  Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants.

Authors:  Kyonghwan Choe; Hyun Young Park; Muhammad Ikram; Hyeon Jin Lee; Tae Ju Park; Rahat Ullah; Myeong Ok Kim
Journal:  Cells       Date:  2022-04-11       Impact factor: 7.666

Review 3.  Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis.

Authors:  Nabab Khan; Jonathan D Geiger
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.048

Review 4.  Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection.

Authors:  Fengling Feng; Jiaoshan Chen; Jin Zhao; Yanjun Li; Minchao Li; Caijun Sun
Journal:  Viruses       Date:  2021-11-08       Impact factor: 5.048

5.  African derived phytocompounds may interfere with SARS-CoV-2 RNA capping machinery via inhibition of 2'-O-ribose methyltransferase: An in silico perspective.

Authors:  Gideon A Gyebi; Oludare M Ogunyemi; Adedotun A Adefolalu; Alejandro Rodríguez-Martínez; Juan F López-Pastor; Antonio J Banegas-Luna; Horacio Pérez-Sánchez; Adegbenro P Adegunloye; Olalekan B Ogunro; Saheed O Afolabi
Journal:  J Mol Struct       Date:  2022-04-12       Impact factor: 3.841

Review 6.  TRP channels in COVID-19 disease: Potential targets for prevention and treatment.

Authors:  Sahar M Jaffal; Manal A Abbas
Journal:  Chem Biol Interact       Date:  2021-06-21       Impact factor: 5.192

7.  mTOR: A possible therapeutic target against SARS-CoV-2 infection.

Authors:  Nabab Khan
Journal:  Arch Stem Cell Ther       Date:  2021
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.